CANNABIS SUISSE CORP. Cash and Equivalents

Quick Answer

CANNABIS SUISSE CORP. reported Cash and Equivalents of $2.9 thousand for fiscal year 2025.

CANNABIS SUISSE CORP. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $2.9K -90.0%
2024 $28.6K +14252.8%
2023 $199.00
2022 $0.00 -100.0%
2020 $5.00 -100.0%
2019 $84.2K +1260.6%
2018 $6.2K +0.0%
2017 $6.2K +480.9%
2016 $1.1K

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
November 30, 2025 $2.6K -36.0% +760.7%
August 31, 2025 $305.00 -98.8% -89.3%
May 31, 2025 $2.9K -90.0% +5600.0%
February 28, 2025 $50.00 +13.6% -98.8%
November 30, 2024 $4.1K -24.7% -84.1%
August 31, 2024 $25.7K +1701.4% -9.9%
May 31, 2024 $28.6K +14252.8% +64813.6%
February 29, 2024 $44.00 -99.1% -99.2%
  • CANNABIS SUISSE CORP. showed a decrease of -90.0% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2016–2025 period, CANNABIS SUISSE CORP.’s cash and equivalents has grown by 167.6% (from $1.1 thousand to $2.9 thousand).
  • The most recent figure is from CANNABIS SUISSE CORP.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 12, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment